Thomas C. Harding
Impact in
- Oncology top 0.5%
- PARP inhibition in cancer therapy
- Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment
Papers in
- Co-authors
- Karin U. Jooss (12 shared papers)Guang Huan Tu (6 shared papers)Melinda J. VanRoey (6 shared papers)Jianmin Fang (2 shared papers)James B. Uney (5 shared papers)Andrew D. Simmons (9 shared papers)Kathryn E. Koprivnikar (5 shared papers)Jingjing Qian (1 shared paper)
- Journals
- Molecular Therapy (4 papers)Cancer Discovery (3 papers)The Lancet Oncology (2 papers)European Journal of Nuclear Medicine and Molecular Imaging (2 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Thomas C. Harding
46 papers receiving 7.1k citations
Thomas C. Harding's Hit Papers
Peers
Comparison fields: 5 of 114
- Oncology 4.3k
- Reproductive Medicine 1.1k
- Cancer Research 906
- Molecular Biology 3.2k
- Pulmonary and Respiratory Medicine 1.3k
Countries citing papers authored by Thomas C. Harding
This map shows the geographic impact of Thomas C. Harding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas C. Harding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas C. Harding more than expected).
Fields of papers citing papers by Thomas C. Harding
This network shows the impact of papers produced by Thomas C. Harding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas C. Harding. The network helps show where Thomas C. Harding may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas C. Harding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2017 | 1394 |
| 2 | Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial Hit paper breakdown → | 2016 | 985 |
| 3 | Discovery of a Mutant-Selective Covalent Inhibitor of EGFR that Overcomes T790M-Mediated Resistance in NSCLC Hit paper breakdown → | 2013 | 564 |
| 4 | Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients Hit paper breakdown → | 2016 | 561 |
| 5 | BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma Hit paper breakdown → | 2018 | 348 |
| 6 | 2017 | 345 | |
| 7 | 2005 | 325 | |
| 8 | 2012 | 314 | |
| 9 | 2018 | 245 | |
| 10 | 2018 | 238 | |
| 11 | 2005 | 213 | |
| 12 | Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy Hit paper breakdown → | 2022 | 211 |
| 13 | 2006 | 202 | |
| 14 | 2002 | 176 | |
| 15 | 1998 | 126 | |
| 16 | 2013 | 110 | |
| 17 | 2001 | 103 | |
| 18 | 2007 | 91 | |
| 19 | 2010 | 81 | |
| 20 | 2004 | 57 |
About Thomas C. Harding
Thomas C. Harding is a scholar working on Oncology, Genetics, Molecular Biology, Reproductive Medicine and Pulmonary and Respiratory Medicine, having authored 46 papers that have together received 7.3k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (14 papers), Virus-based gene therapy research (11 papers), CRISPR and Genetic Engineering (9 papers), CAR-T cell therapy research (5 papers), DNA Repair Mechanisms (5 papers), Lung Cancer Treatments and Mutations (4 papers), Ovarian cancer diagnosis and treatment (3 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). The work is most often cited by research in Oncology (4.3k citations), Reproductive Medicine (1.1k citations), Cancer Research (906 citations), Molecular Biology (3.2k citations) and Pulmonary and Respiratory Medicine (1.3k citations). Thomas C. Harding has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Karin U. Jooss, Guang Huan Tu, Melinda J. VanRoey, Jianmin Fang, James B. Uney, Andrew D. Simmons, Kathryn E. Koprivnikar, Jingjing Qian, Bo Luan and Alshad S. Lalani. Their work appears in journals such as Molecular Therapy, Cancer Discovery, The Lancet Oncology, European Journal of Nuclear Medicine and Molecular Imaging and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.